JONATHAN MICHAEL YINGLING Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JONATHAN MICHAEL YINGLING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN MICHAEL YINGLING. JONATHAN MICHAEL YINGLING is Chief Scientific Officer in IDERA PHARMACEUTICALS, INC. ($IDRA) and SVP of Early Development in IDERA PHARMACEUTICALS, INC. ($IDRA) and SVP, Early Development in IDERA PHARMACEUTICALS, INC. ($IDRA) and Chief Scientific Officer in BIND Therapeutics, Inc ($BIND).
JONATHAN MICHAEL YINGLING in IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JONATHAN MICHAEL YINGLING: Chief Scientific Officer, SVP, Early Development, SVP of Early Development
Holdings: 36,358 shares
Current Value: $56,718
Latest Transaction: Jan 14 2020
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JONATHAN MICHAEL YINGLING in IDERA PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 1.79 | 50,000 | 89,500 | 50,000 | |
| Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Grant | A | 0.00 | 20,000 | 0 | 36,358 | 16.4 K to 36.4 K (+122.26 %) |
| Jan 10 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Sell | S | 1.78 | 1,742 | 3,101 | 16,358 | 18.1 K to 16.4 K (-9.62 %) |
| Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 2.52 | 45,500 | 114,660 | 45,500 | |
| Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 3.14 | 45,500 | 142,870 | 45,500 | |
| Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Grant | A | 0.00 | 18,100 | 0 | 18,100 | 0 to 18.1 K |
| Aug 15 2018 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 7.39 | 32,500 | 240,175 | 32,500 | |
| Jan 05 2018 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | SVP, Early Developm ... | Option Exercise | A | 2.24 | 270,000 | 604,800 | 270,000 | |
| Feb 08 2017 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | SVP of Early Develo ... | Option Exercise | A | 1.55 | 275,000 | 426,250 | 275,000 | |
| Feb 08 2017 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | SVP of Early Develo ... | Option Exercise | A | 1.55 | 325,000 | 503,750 | 325,000 |
Page: 1